Table 1.
The frequency of MYD88L265P in B-cell lymphoproliferative disorders.
| Entity | N | MYD88L265P Range | References |
|---|---|---|---|
| Waldenström’s macroglobulinemia | 470 | 67–100% | [11,12,13,14,15,50,51,52,56] |
| IgM-MGUS | 164 | 10–87% | [11,12,13,14,15,46] |
| MALT lymphoma | 105 | 0–9% | [23,50,54] |
| MZL | 325 | 0–21% | [11,12,13,14,15,50,53,54] |
| Multiple myeloma (including IgM) | 188 | 0% | [11,13,14,15,51,53,55,56] |
| Chronic lymphocytic leukemia | 412 | 0–43% 1 | [13,14,15,24,52,53,56] |
1 Forty-three percent in a series of CLL with an IgM component. IgM-MGUS, IgM monoclonal gammopathy of undetermined significance; MALT, mucosa-associated lymphoid tissue; MZL, marginal zone lymphoma.